Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.27
ESLOY's Cash to Debt is ranked lower than
79% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. ESLOY: 0.27 )
Ranked among companies with meaningful Cash to Debt only.
ESLOY' s 10-Year Cash to Debt Range
Min: 0.23   Max: 1.63
Current: 0.27

0.23
1.63
Equity to Asset 0.46
ESLOY's Equity to Asset is ranked lower than
72% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. ESLOY: 0.46 )
Ranked among companies with meaningful Equity to Asset only.
ESLOY' s 10-Year Equity to Asset Range
Min: 0.46   Max: 0.65
Current: 0.46

0.46
0.65
F-Score: 6
Z-Score: 3.97
M-Score: -2.43
WACC vs ROIC
4.27%
17.63%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 21.55
ESLOY's Operating margin (%) is ranked higher than
88% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. ESLOY: 21.55 )
Ranked among companies with meaningful Operating margin (%) only.
ESLOY' s 10-Year Operating margin (%) Range
Min: 15   Max: 21.55
Current: 21.55

15
21.55
Net-margin (%) 16.38
ESLOY's Net-margin (%) is ranked higher than
88% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. ESLOY: 16.38 )
Ranked among companies with meaningful Net-margin (%) only.
ESLOY' s 10-Year Net-margin (%) Range
Min: 6.89   Max: 16.38
Current: 16.38

6.89
16.38
ROE (%) 21.37
ESLOY's ROE (%) is ranked higher than
89% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. ESLOY: 21.37 )
Ranked among companies with meaningful ROE (%) only.
ESLOY' s 10-Year ROE (%) Range
Min: 14.81   Max: 21.43
Current: 21.37

14.81
21.43
ROA (%) 9.74
ESLOY's ROA (%) is ranked higher than
79% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. ESLOY: 9.74 )
Ranked among companies with meaningful ROA (%) only.
ESLOY' s 10-Year ROA (%) Range
Min: 8.19   Max: 11.16
Current: 9.74

8.19
11.16
ROC (Joel Greenblatt) (%) 69.63
ESLOY's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.83 vs. ESLOY: 69.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ESLOY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 41.23   Max: 75.21
Current: 69.63

41.23
75.21
Revenue Growth (3Y)(%) 9.70
ESLOY's Revenue Growth (3Y)(%) is ranked higher than
76% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. ESLOY: 9.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ESLOY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.5   Max: 15.1
Current: 9.7

-0.5
15.1
EBITDA Growth (3Y)(%) 23.70
ESLOY's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. ESLOY: 23.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ESLOY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -2.2   Max: 23.7
Current: 23.7

-2.2
23.7
EPS Growth (3Y)(%) 21.50
ESLOY's EPS Growth (3Y)(%) is ranked higher than
73% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. ESLOY: 21.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ESLOY' s 10-Year EPS Growth (3Y)(%) Range
Min: 7   Max: 21.5
Current: 21.5

7
21.5
» ESLOY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with ESLOY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.80
ESLOY's P/E(ttm) is ranked higher than
63% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.20 vs. ESLOY: 25.80 )
Ranked among companies with meaningful P/E(ttm) only.
ESLOY' s 10-Year P/E(ttm) Range
Min: 14.54   Max: 57.75
Current: 25.8

14.54
57.75
Forward P/E 14.08
ESLOY's Forward P/E is ranked higher than
84% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.03 vs. ESLOY: 14.08 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.10
ESLOY's PE(NRI) is ranked higher than
56% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.40 vs. ESLOY: 26.10 )
Ranked among companies with meaningful PE(NRI) only.
ESLOY' s 10-Year PE(NRI) Range
Min: 14.7   Max: 58.89
Current: 26.1

14.7
58.89
P/B 4.70
ESLOY's P/B is ranked lower than
70% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.26 vs. ESLOY: 4.70 )
Ranked among companies with meaningful P/B only.
ESLOY' s 10-Year P/B Range
Min: 2.36   Max: 9.89
Current: 4.7

2.36
9.89
P/S 4.23
ESLOY's P/S is ranked lower than
83% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.22 vs. ESLOY: 4.23 )
Ranked among companies with meaningful P/S only.
ESLOY' s 10-Year P/S Range
Min: 1.83   Max: 7.2
Current: 4.23

1.83
7.2
PFCF 29.80
ESLOY's PFCF is ranked lower than
60% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.81 vs. ESLOY: 29.80 )
Ranked among companies with meaningful PFCF only.
ESLOY' s 10-Year PFCF Range
Min: 18.02   Max: 78.53
Current: 29.8

18.02
78.53
POCF 23.48
ESLOY's POCF is ranked lower than
71% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.50 vs. ESLOY: 23.48 )
Ranked among companies with meaningful POCF only.
ESLOY' s 10-Year POCF Range
Min: 11.29   Max: 43.04
Current: 23.48

11.29
43.04
EV-to-EBIT 21.40
ESLOY's EV-to-EBIT is ranked higher than
50% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.40 vs. ESLOY: 21.40 )
Ranked among companies with meaningful EV-to-EBIT only.
ESLOY' s 10-Year EV-to-EBIT Range
Min: 11.1   Max: 41.6
Current: 21.4

11.1
41.6
PEG 1.68
ESLOY's PEG is ranked higher than
71% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. ESLOY: 1.68 )
Ranked among companies with meaningful PEG only.
ESLOY' s 10-Year PEG Range
Min: 1.08   Max: 26.06
Current: 1.68

1.08
26.06
Shiller P/E 39.40
ESLOY's Shiller P/E is ranked lower than
65% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.00 vs. ESLOY: 39.40 )
Ranked among companies with meaningful Shiller P/E only.
ESLOY' s 10-Year Shiller P/E Range
Min: 17.42   Max: 40.57
Current: 39.4

17.42
40.57
Current Ratio 1.07
ESLOY's Current Ratio is ranked lower than
91% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. ESLOY: 1.07 )
Ranked among companies with meaningful Current Ratio only.
ESLOY' s 10-Year Current Ratio Range
Min: 1.07   Max: 2.57
Current: 1.07

1.07
2.57
Quick Ratio 0.73
ESLOY's Quick Ratio is ranked lower than
89% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. ESLOY: 0.73 )
Ranked among companies with meaningful Quick Ratio only.
ESLOY' s 10-Year Quick Ratio Range
Min: 0.73   Max: 2.03
Current: 0.73

0.73
2.03
Days Inventory 144.66
ESLOY's Days Inventory is ranked lower than
59% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. ESLOY: 144.66 )
Ranked among companies with meaningful Days Inventory only.
ESLOY' s 10-Year Days Inventory Range
Min: 113.1   Max: 144.99
Current: 144.66

113.1
144.99

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.90
ESLOY's Dividend Yield is ranked lower than
67% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. ESLOY: 0.90 )
Ranked among companies with meaningful Dividend Yield only.
ESLOY' s 10-Year Dividend Yield Range
Min: 0.82   Max: 7.37
Current: 0.9

0.82
7.37
Dividend Payout 0.22
ESLOY's Dividend Payout is ranked higher than
74% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.38 vs. ESLOY: 0.22 )
Ranked among companies with meaningful Dividend Payout only.
ESLOY' s 10-Year Dividend Payout Range
Min: 0.22   Max: 1.07
Current: 0.22

0.22
1.07
Dividend growth (3y) 4.20
ESLOY's Dividend growth (3y) is ranked lower than
67% of the 57 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. ESLOY: 4.20 )
Ranked among companies with meaningful Dividend growth (3y) only.
ESLOY' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 45.5
Current: 4.2

0
45.5
Yield on cost (5-Year) 1.28
ESLOY's Yield on cost (5-Year) is ranked lower than
58% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. ESLOY: 1.28 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ESLOY' s 10-Year Yield on cost (5-Year) Range
Min: 1.17   Max: 10.48
Current: 1.28

1.17
10.48
Share Buyback Rate -0.80
ESLOY's Share Buyback Rate is ranked higher than
64% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. ESLOY: -0.80 )
Ranked among companies with meaningful Share Buyback Rate only.
ESLOY' s 10-Year Share Buyback Rate Range
Min: 0.9   Max: -2.6
Current: -0.8

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 2.00
ESLOY's Price/DCF (Projected) is ranked lower than
61% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. ESLOY: 2.00 )
Ranked among companies with meaningful Price/DCF (Projected) only.
ESLOY' s 10-Year Price/DCF (Projected) Range
Min: 1.42   Max: 2.43
Current: 2

1.42
2.43
Price/Median PS Value 1.40
ESLOY's Price/Median PS Value is ranked lower than
56% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. ESLOY: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
ESLOY' s 10-Year Price/Median PS Value Range
Min: 0.52   Max: 1.11
Current: 1.4

0.52
1.11
Price/Peter Lynch Fair Value 1.50
ESLOY's Price/Peter Lynch Fair Value is ranked higher than
68% of the 71 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. ESLOY: 1.50 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ESLOY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.05   Max: 3.45
Current: 1.5

1.05
3.45
Earnings Yield (Greenblatt) 4.90
ESLOY's Earnings Yield (Greenblatt) is ranked higher than
71% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. ESLOY: 4.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
ESLOY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.4   Max: 9
Current: 4.9

2.4
9
Forward Rate of Return (Yacktman) 19.71
ESLOY's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.95 vs. ESLOY: 19.71 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
ESLOY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.2   Max: 20.4
Current: 19.71

2.2
20.4

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Traded in other countries:EI.France, 0OMK.UK, ESL.Germany, EINV.France, EI.Switzerland, EI N.Mexico,
Essilor International SA was formed on October 6, 1971. The Company designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures, purchases and sales frames, sunglasses, protective lenses and other protective equipment, and eyeglass and contact lenses. The Company operates in three business segments: Lenses & Optical Instruments, Equipment, and Readers. The Lenses & Optical Instruments business segment comprises the Lens business (production, finishing, distribution and trading) and the Instruments business (small equipment used by opticians and relating to the sale of lenses). The end customers for this business are eye care professionals. The Equipment business segment comprises the production, distribution and sale of high capacity equipment, such as digital surfacing machines and lens polishing machines, used in manufacturing plants and prescription laboratories for finishing operations on semi-finished lenses. The end customers for this business segment are optical lens manufacturers. The Readers business segment comprises the production, distribution and sale of non-prescription reading glasses and sunglasses. The end customers for this segment are retailers that sell non-prescription reading glasses to consumers. It operates in North America, Europe, Asia-Pacific/Middle East/Africa, and Latin America. The Company's competitors are Hoya (Japan) and Carl Zeiss Vision (Germany).

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK